Company Financials

Gan & Lee Pharmaceuticals Co. Ltd Financials

Renminbi

business Gan & Lee Pharmaceuticals Co. Ltd Company Profile

Main Stock Listing

SSE: 603087

Market Capitalization CN¥33.89 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 39.99
Forward PE 29.68
Price to Sales TTM CN¥9.77
Price to Book MRQ CN¥2.93
Enterprise to Revenue 8.61
Enterprise to EBITDA 38.72

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 23.94%
Operating Margin 22.69%
Return on Assets TTM 2.67%
Return on Equity TTM 7.50%

Income Statement

Revenue TTM CN¥3,469,881,088
Revenue per Share TTM CN¥5.90
Quarterly Revenue Growth 75.80%
Gross Profit TTM CN¥2,616,075,264
EBITDA CN¥726,951,180
Net Income to Common TTM CN¥830,578,304
Diluted EPS TTM CN¥1.41
Quarterly Earnings Growth YoY 224.90%

Balance Sheet

Total Cash MRQ CN¥2,356,538,112
Total Cash per Share MRQ CN¥4.00
Total Debt MRQ CN¥
Total Debt to Equity MRQ 0.03
Current Ratio MRQ 4.92
Book Value per Share MRQ CN¥19.22

Cash Flow

Operating Cash Flow TTM CN¥614,767,616
Levered Free Cash Flow TTM CN¥113,391,376

603087 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 601,065,290
Float Shares 336,583,844
Avg 10 Volume 10,222,009
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 45.02%
% Held by Institutions 7.17%

Stock Price Summary

Beta 1.61
Fifty Two Week Low CN¥37.63
Fifty Two Week High CN¥59.16
Fifty Two Week Change 24.84%
Day 50 MA CN¥52.49
Day 200 MA CN¥47.03

Dividends and Splits

Forward Annual Dividend Rate CN¥4.00
Forward Annual Dividend Yield 7.12%
Trailing Annual Dividend Rate CN¥1.00
Trailing Annual Dividend Yield 1.78%
Payout Ratio 49.65%
Dividend Date
Ex Dividend Date 2025-06-11
Last Split Factor
Last Split Date 2020-08-20